E-LIB Suche - Ergebnisse für: Moyo, Tamara K. - Sprache DE

OpenAccess-Volltexte X

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

Postibrutinib relapse outcomes for patients with marginal z..:

Epperla, Narendranath ; Zhao, Qiuhong ; Chowdhury, Sayan Mullick...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827027/. , 2022

Link: http://www.ncbi.nlm.nih...

2

Predictive Factors and Outcomes for Ibrutinib in Relapsed/r..:

Epperla, Narendranath ; Zhao, Qiuhong ; Chowdhury, Sayan Mullick...
https://jdc.jefferson.edu/medfp/365. , 2022

Link: https://jdc.jefferson.ed..

3

The ABNL-MARRO 001 study : a phase 1-2 study of randomly al..:

Moyo, Tamara K ; Mendler, Jason H ; Itzykson, Raphael...
BMC Cancer. , 2022

Link: https://ddd.uab.cat/reco..

4

The ABNL-MARRO 001 study: a phase 1–2 study of randomly all..:

Moyo, Tamara K ; Mendler, Jason H ; Itzykson, Raphael...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509596/. , 2022

Link: http://www.ncbi.nlm.nih...

5

The ABNL-MARRO 001 study: a phase 1–2 study of randomly all..:

Moyo, Tamara K ; Lübbert, Michael ; Savona, Michael R.
https://freidok.uni-freiburg.de/data/231239. , 2022

Link: https://freidok.uni-frei..

6

Peri–CAR-T practice patterns and survival predictors for al..:

Zurko, Joanna ; Nizamuddin, Imran ; Epperla, Narendranath...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333741/. , 2022

Link: http://www.ncbi.nlm.nih...

7

Predictive factors and outcomes for ibrutinib in relapsed/r..:

Epperla, Narendranath ; Zhao, Qiuhong ; Chowdhury, Sayan Mullick...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287914/. , 2022

Link: http://www.ncbi.nlm.nih...

8

A Review of Chimeric Antigen Receptor T-Cell Therapy for My..:

Atrash, Shebli ; Moyo, Tamara K
info:eu-repo/semantics/altIdentifier/doi/10.2147/OTT.S242018. , 2021

Link: https://www.dovepress.co..

9

The delta isoform of PI3K predominates in chronic myelomono..:

Villaume, Matthew T ; Arrate, M. Pia ; Ramsey, Haley E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059134/. , 2021

Link: http://www.ncbi.nlm.nih...

10

A Review of Chimeric Antigen Receptor T-Cell Therapy for My..:

Atrash, Shebli ; Moyo, Tamara K
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009535/. , 2021

Link: http://www.ncbi.nlm.nih...

11

Acceleration of spleen segmentation with end-to-end deep le..:

Moon, Hyeonsoo ; Huo, Yuankai ; Abramson, Richard G...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086455/. , 2019

Link: http://www.ncbi.nlm.nih...

12

Splenomegaly Segmentation on Multi-modal MRI using Deep Con..:

Huo, Yuankai ; Xu, Zhoubing ; Bao, Shunxing...
http://arxiv.org/abs/1811.04045. , 2018

Link: http://arxiv.org/abs/181..

13

SynSeg-Net: Synthetic Segmentation Without Target Modality ..:

Huo, Yuankai ; Xu, Zhoubing ; Moon, Hyeonsoo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504618/. , 2018

Link: http://www.ncbi.nlm.nih...

14

Genotypic and Clinical Heterogeneity Within NCCN Favorable-..:

Strickland, Stephen A ; Shaver, Aaron C ; Byrne, Michael...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856485/. , 2018

Link: http://www.ncbi.nlm.nih...

15

SynSeg-Net: Synthetic Segmentation Without Target Modality ..:

Huo, Yuankai ; Xu, Zhoubing ; Moon, Hyeonsoo...
http://arxiv.org/abs/1810.06498. , 2018

Link: http://arxiv.org/abs/181..

1-15